All Stories

  1. Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD – 2019 update of evidence
  2. Late Breaking Abstract - Influence of salbutamol use on symptomatic outcomes with maintenance bronchodilators: a pre-specified analysis of the EMAX trial
  3. Improving COPD symptoms with umeclidinium/vilanterol and impact of baseline disease severity: the EMAX trial
  4. Reliability of quadriceps muscle power and explosive force, and relationship to physical function in people with chronic obstructive pulmonary disease: an observational prospective multicenter study
  5. Feasibility of an eight-week telerehabilitation intervention for patients with unresectable thoracic neoplasia receiving chemotherapy: A pilot study
  6. Chylothorax in Behçet’s disease
  7. Longitudinal comparison of outcomes in patients with smoking-related asthma-COPD overlap and in non-smoking asthmatics with incomplete reversibility of airway obstruction
  8. Tiotropium/olodaterol reduces activity-related breathlessness versus tiotropium in COPD
  9. Ectopic adiposity and cardiometabolic health in COPD
  10. Relationship between exercise endurance and static hyperinflation in a post hoc analysis of two clinical trials in patients with COPD
  11. Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease
  12. Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy
  13. Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow Limitation
  14. Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD
  15. Automated oxygen titration and weaning with FreeO2 in patients with acute exacerbation of COPD: a pilot randomized trial
  16. A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 µg compared with tiotropium 18 µg in patients with COPD
  17. Test-retest reliability of lower limb isokinetic endurance in COPD: a comparison of angular velocities